IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.

@article{Kirnbauer1989IFNbeta2B,
  title={IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.},
  author={Reinhard Kirnbauer and Andreas Koeck and Thomas P. Schwarz and Agatha Urbanski and Jean Krutmann and Wolfgang Borth and Danielle Damm and Greg Shipley and John C. Ansel and Thomas Anton Luger},
  journal={Journal of immunology},
  year={1989},
  volume={142 6},
  pages={
          1922-8
        }
}
IL-6, which is also known as IFN-beta 2, hybridoma growth factor, hepatocyte-stimulating factor, and B cell differentiation factor, mediates acute phase responses including fever, has lymphocyte-stimulating capacities, and antiviral activity. IL-6 is produced by monocytes, fibroblasts, certain lymphocytes, and various tumor cells. The present study demonstrates that this multifunctional cytokine is released also by normal human epidermal cells (EC) and human epidermoid carcinoma cell lines… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS